FDA NDC Directory · JSON-LD · Markdown

ELAPRASE

NDC 54092-700 · HUMAN PRESCRIPTION DRUG · SOLUTION, CONCENTRATE

Generic nameidursulfase
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryBiologic License Application · App BLA125151
Dosage form / routeSOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsIDURSULFASE (6 mg/3mL)
Marketing started20060724
Package count1

External sources

Source: openFDA. Public-domain (CC0).